Skip to Main Content

Paper Details

Nonselective beta-blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States.
Aliment Pharmacol Ther
22
2021
Author NameAffiliation
Yang Xiang
Cong ZhuSchool of Public Health, The University of Texas Health Science Center at Houston
Vahed MaroufySchool of Public Health, The University of Texas Health Science Center at Houston
Yifang DangThe University of Texas Health Science Center at Houston
Hua XuThe University of Texas Health Science Center at Houston
Cui TaoThe University of Texas Health Science Center at Houston
  • 1 - 6

Datasets